Other Species / Isoforms
  ANKZF1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsPAPDAAP
0 1
ANKZF1 (human) ______MsPAPDAAP S2-p
ANKZF1 (mouse) SVSSSATSPAPSAAP S28
ANKZF1 (rat) gap -
S15-p
APAPASIsLFDLSAD
0 1
ANKZF1 (human) APAPASIsLFDLSAD S15-p
ANKZF1 (mouse) APAPASVSLLSLNGE S41
ANKZF1 (rat) APVPASVSLLTLNGE S15
T46-p
ALARAPRtsCsGsGE
0 1
ANKZF1 (human) ALARAPRtsCsGsGE T46-p
ANKZF1 (mouse) ALAWAPRTSCPGENT T72
ANKZF1 (rat) ALAWAPRTSCPGENT T46
S47-p
LARAPRtsCsGsGER
0 1
ANKZF1 (human) LARAPRtsCsGsGER S47-p
ANKZF1 (mouse) LAWAPRTSCPGENTS S73
ANKZF1 (rat) LAWAPRTSCPGENTS S47
S49-p
RAPRtsCsGsGEREs
0 1
ANKZF1 (human) RAPRtsCsGsGEREs S49-p
ANKZF1 (mouse) WAPRTSCPGENTSSG P75
ANKZF1 (rat) WAPRTSCPGENTSSG P49
S51-p
PRtsCsGsGEREsPE
0 2
ANKZF1 (human) PRtsCsGsGEREsPE S51-p
ANKZF1 (mouse) gap -
ANKZF1 (rat) gap -
S56-p
sGsGEREsPERKLLQ
0 5
ANKZF1 (human) sGsGEREsPERKLLQ S56-p
ANKZF1 (mouse) SCPGENTSSGGKVsP S80
ANKZF1 (rat) SCPGENTSSGRKVSP S54
L62
EsPERKLLQGPMDIS
0 5
ANKZF1 (human) EsPERKLLQGPMDIS L62
ANKZF1 (mouse) TSSGGKVsPySLEIS S86-p
ANKZF1 (rat) TSSGRKVSPCSLDIS S60
G64
PERKLLQGPMDISEK
0 1
ANKZF1 (human) PERKLLQGPMDISEK G64
ANKZF1 (mouse) SGGKVsPySLEISEK Y88-p
ANKZF1 (rat) SGRKVSPCSLDISDK C62
K101-m1
DWHRFNLkQRLKDKP
0 1
ANKZF1 (human) DWHRFNLkQRLKDKP K101-m1
ANKZF1 (mouse) DWHRFNLKQRLKNKP K125
ANKZF1 (rat) DWHRFNLKQRLKNKP K99
L113
DKPLLSALDFEKQSS
0 1
ANKZF1 (human) DKPLLSALDFEKQSS L113
ANKZF1 (mouse) NKPLLSASDFEQQSS S137
ANKZF1 (rat) NKPLLSAsDFERQSS S111-p
Y176-p
NAQGQFLyAYRCVLG
0 1
ANKZF1 (human) NAQGQFLyAYRCVLG Y176-p
ANKZF1 (mouse) NAQGQFLYAYRCVLG Y200
ANKZF1 (rat) NAQGQFLYAYRCVLG Y174
R242-m1
RYTVRAKrGTAQGLR
0 2
ANKZF1 (human) RYTVRAKrGTAQGLR R242-m1
ANKZF1 (mouse) RYTVRAKRGTAQGLQ R266
ANKZF1 (rat) RYTVRAKRGTAQGLQ R240
R252-m1
AQGLRDArGGPSHsA
0 11
ANKZF1 (human) AQGLRDArGGPSHsA R252-m1
ANKZF1 (mouse) AQGLQDAHGRASRSA H276
ANKZF1 (rat) AQGLQDAQGRASRSA Q250
S258-p
ArGGPSHsAGANLRR
Upstream
0 3
Treatment
  • nocodazole
ANKZF1 (human) ArGGPSHsAGANLRR S258-p
ANKZF1 (mouse) AHGRASRSAGANLRR S282
ANKZF1 (rat) AQGRASRSAGANLRR S256
K273-ub
YNEATLYkDVRDLLA
0 2
ANKZF1 (human) YNEATLYkDVRDLLA K273-ub
ANKZF1 (mouse) YNEAMLYKDVRNLLA K297
ANKZF1 (rat) YNEAMLYKDVRDLLA K271
K286-ub
LAGPSWAkALEEAGT
0 1
ANKZF1 (human) LAGPSWAkALEEAGT K286-ub
ANKZF1 (mouse) LAGPIWSKALGEAET K310
ANKZF1 (rat) LAGPTWSKALGEAET K284
K310-ac
RSLFFGGkGAPLQRG
0 4
ANKZF1 (human) RSLFFGGkGAPLQRG K310-ac
ANKZF1 (mouse) RSLFFGGQGAPLQRD Q334
ANKZF1 (rat) RSLFFGGQGAPLQRS Q308
K310-ub
RSLFFGGkGAPLQRG
0 2
ANKZF1 (human) RSLFFGGkGAPLQRG K310-ub
ANKZF1 (mouse) RSLFFGGQGAPLQRD Q334
ANKZF1 (rat) RSLFFGGQGAPLQRS Q308
S361-p
REAVRLHsPQtHWkT
Upstream
0 36
Treatment
  • BI_4834
  • nocodazole
ANKZF1 (human) REAVRLHsPQtHWkT S361-p
ANKZF1 (mouse) REMVRFHsPETHWKP S385-p
ANKZF1 (rat) REMVRFHSPETHCKP S359
T364-p
VRLHsPQtHWkTVRE
0 5
ANKZF1 (human) VRLHsPQtHWkTVRE T364-p
ANKZF1 (mouse) VRFHsPETHWKPVRE T388
ANKZF1 (rat) VRFHSPETHCKPVRE T362
K367-ub
HsPQtHWkTVREERK
0 1
ANKZF1 (human) HsPQtHWkTVREERK K367-ub
ANKZF1 (mouse) HsPETHWKPVREERK K391
ANKZF1 (rat) HSPETHCKPVREERK K365
S398-p
ALGQNEEsPKQGSGS
0 11
ANKZF1 (human) ALGQNEEsPKQGSGS S398-p
ANKZF1 (mouse) PLGQDEEPLKQGSEs P422
ANKZF1 (rat) ALGQDEEPLKQGSES P396
S405
sPKQGSGSEGEDGFQ
0 1
ANKZF1 (human) sPKQGSGSEGEDGFQ S405
ANKZF1 (mouse) PLKQGSEsQEEDGsE S429-p
ANKZF1 (rat) PLKQGSESQEEDGSE S403
F411
GSEGEDGFQVELELV
0 1
ANKZF1 (human) GSEGEDGFQVELELV F411
ANKZF1 (mouse) EsQEEDGsEVELELV S435-p
ANKZF1 (rat) ESQEEDGSEVELELV S409
K511-ub
AGDVGVLkLQLAPSP
0 1
ANKZF1 (human) AGDVGVLkLQLAPSP K511-ub
ANKZF1 (mouse) AGEVEVLKLQLATGL K533
ANKZF1 (rat) AGEVEVLKLQLATGP K507
S533-p
LLSAPLGsGGFTLLH
Upstream
0 12
Treatment
  • nocodazole
ANKZF1 (human) LLSAPLGsGGFTLLH S533-p
ANKZF1 (mouse) LLNAPLGSGGFTLLH S555
ANKZF1 (rat) LLSAPLGSGGFTLLH S529
Y572-p
DSRARPPyTVAADKs
0 1
ANKZF1 (human) DSRARPPyTVAADKs Y572-p
ANKZF1 (mouse) DSRARPPYTVAADKS Y594
ANKZF1 (rat) DSRARPPYTVAADRS Y568
S579-p
yTVAADKstRNEFRR
0 1
ANKZF1 (human) yTVAADKstRNEFRR S579-p
ANKZF1 (mouse) YTVAADKSTRNEFRR S601
ANKZF1 (rat) YTVAADRSTRNEFRR S575
T580-p
TVAADKstRNEFRRF
0 1
ANKZF1 (human) TVAADKstRNEFRRF T580-p
ANKZF1 (mouse) TVAADKSTRNEFRRF T602
ANKZF1 (rat) TVAADRSTRNEFRRF T576
K599-m1
PDAYDYNkAQVPGPL
0 1
ANKZF1 (human) PDAYDYNkAQVPGPL K599-m1
ANKZF1 (mouse) LDAYDYNKARVPGPL K621
ANKZF1 (rat) LDAYDYSKARVPGPL K595
T607-p
AQVPGPLtPEMEARQ
0 100
ANKZF1 (human) AQVPGPLtPEMEARQ T607-p
ANKZF1 (mouse) ARVPGPLTQEMEARQ T629
ANKZF1 (rat) ARVPGPLTQEMEARQ T603
T674-p
AAQLGAPtsPIPDsA
0 2
ANKZF1 (human) AAQLGAPtsPIPDsA T674-p
ANKZF1 (mouse) AAQLGAPSPPVPDSA S696
ANKZF1 (rat) AAQLGAPSPPVPDSA S670
S675-p
AQLGAPtsPIPDsAI
Upstream
0 11
Treatment
  • selumetinib
  • vemurafenib
ANKZF1 (human) AQLGAPtsPIPDsAI S675-p
ANKZF1 (mouse) AQLGAPSPPVPDSAV P697
ANKZF1 (rat) AQLGAPSPPVPDSAV P671
S680-p
PtsPIPDsAIVNTRR
0 1
ANKZF1 (human) PtsPIPDsAIVNTRR S680-p
ANKZF1 (mouse) PSPPVPDSAVASAGR S702
ANKZF1 (rat) PSPPVPDSAVVNAGR S676